Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes.

作者: Caroline Ketterer , Karsten Müssig , Martin Heni , Katarzyna Dudziak , Elko Randrianarisoa

DOI: 10.1016/J.METABOL.2011.02.002

关键词: Single-nucleotide polymorphismInsulinType 2 Diabetes MellitusMinor allele frequencyInternal medicineBody mass indexType 2 diabetesEndocrinologyAlleleBiologyArea under the curve

摘要: Abstract The functional knockout of the calcium-sensitive, nonselective cation channel TRPM5 alters glucose-induced insulin secretion and glucose tolerance. We hypothesized that genetic variation in gene may contribute to prediabetic phenotypes, including pancreatic β-cell dysfunction. genotyped 1798 white subjects at increased type 2 diabetes mellitus risk for 9 single nucleotide polymorphisms (namely, rs2301696, rs800344, rs800345, rs800347, rs800348, rs2074234, rs2301698, rs886277, rs2301699) also performed correlational analyses with metabolic traits. An oral tolerance test (OGTT) was conducted on all subjects, a subset (n = 525) additionally underwent hyperinsulinemic-euglycemic clamp. chosen cover 100% common (minor allele frequency ≥0.05) within locus (D' 1.0; r² ≥ 0.8). Rs800344, rs2301699 were significantly associated area under curve (AUC) during OGTT additive dominant models after adjustment sex, age, body mass index (all Ps ≤ .0025). Furthermore, rs800344 2-hour model (P .0009). After stratification ratio AUC 0 30 minutes women .0097), but not men .3), model. Female minor carriers showed lower glucagon-like peptide–1 levels compared major homozygotes .0124), whereas male no significant differences found .3). In our German population, variants are likely be phenotypes; this turn development mellitus.

参考文章(43)
Robert Kraft, Christian Harteneck, The mammalian melastatin-related transient receptor potential cation channels: an overview Pflügers Archiv: European Journal of Physiology. ,vol. 451, pp. 204- 211 ,(2005) , 10.1007/S00424-005-1428-0
Karsten Müssig, Harald Staiger, Fausto Machicao, Jürgen Machann, Fritz Schick, Silke A Schäfer, Claus D Claussen, Jens J Holst, Baptist Gallwitz, Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring, None, Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus Metabolism. ,vol. 58, pp. 1809- 1811 ,(2009) , 10.1016/J.METABOL.2009.06.012
Dorothee M Baur, Jens Klotsche, Ole-Petter R Hamnvik, Caroline Sievers, Lars Pieper, Hans-Ulrich Wittchen, Günter K Stalla, Roland M Schmid, Stefanos N Kales, Christos S Mantzoros, None, Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism-clinical and Experimental. ,vol. 60, pp. 1363- 1371 ,(2011) , 10.1016/J.METABOL.2010.09.012
S. B. Gabriel, G.-W. Chirn, Q. Ma, H. Parikh, D. Richardson, D. Ricke, S. Purcell, , R. Saxena, B. F. Voight, V. Lyssenko, N. P. Burtt, P. I. W. de Bakker, H. Chen, J. J. Roix, S. Kathiresan, J. N. Hirschhorn, M. J. Daly, T. E. Hughes, L. Groop, D. Altshuler, P. Almgren, J. C. Florez, J. Meyer, K. Ardlie, K. Bengtsson Bostrom, B. Isomaa, G. Lettre, U. Lindblad, H. N. Lyon, O. Melander, C. Newton-Cheh, P. Nilsson, M. Orho-Melander, L. Rastam, E. K. Speliotes, M.-R. Taskinen, T. Tuomi, C. Guiducci, A. Berglund, J. Carlson, L. Gianniny, R. Hackett, L. Hall, J. Holmkvist, E. Laurila, M. Sjogren, M. Sterner, A. Surti, M. Svensson, M. Svensson, R. Tewhey, B. Blumenstiel, M. Parkin, M. DeFelice, R. Barry, W. Brodeur, J. Camarata, N. Chia, M. Fava, J. Gibbons, B. Handsaker, C. Healy, K. Nguyen, C. Gates, C. Sougnez, D. Gage, M. Nizzari, Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels Science. ,vol. 316, pp. 1331- 1336 ,(2007) , 10.1126/SCIENCE.1142358
TIH Project, None, The International HapMap Project Nature. ,vol. 426, pp. 789- 796 ,(2003) , 10.1038/NATURE02168
Hyeung-Jin Jang, Zaza Kokrashvili, Michael J Theodorakis, Olga D Carlson, Byung-Joon Kim, Jie Zhou, Hyeon Ho Kim, Xiangru Xu, Sic L Chan, Magdalena Juhaszova, Michel Bernier, Bedrich Mosinger, Robert F Margolskee, Josephine M Egan, None, Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 15069- 15074 ,(2007) , 10.1073/PNAS.0706890104
Hiroyuki Unoki, Atsushi Takahashi, Takahisa Kawaguchi, Kazuo Hara, Momoko Horikoshi, Gitte Andersen, Daniel P K Ng, Johan Holmkvist, Knut Borch-Johnsen, Torben Jørgensen, Annelli Sandbæk, Torsten Lauritzen, Torben Hansen, Siti Nurbaya, Tatsuhiko Tsunoda, Michiaki Kubo, Tetsuya Babazono, Hiroshi Hirose, Matsuhiko Hayashi, Yasuhiko Iwamoto, Atsunori Kashiwagi, Kohei Kaku, Ryuzo Kawamori, E Shyong Tai, Oluf Pedersen, Naoyuki Kamatani, Takashi Kadowaki, Ryuichi Kikkawa, Yusuke Nakamura, Shiro Maeda, SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations Nature Genetics. ,vol. 40, pp. 1098- 1102 ,(2008) , 10.1038/NG.208
C F Deacon, A H Johnsen, J J Holst, Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. The Journal of Clinical Endocrinology & Metabolism. ,vol. 80, pp. 952- 957 ,(1995) , 10.1210/JCEM.80.3.7883856
Jose C. Florez, The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008 The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 4633- 4642 ,(2008) , 10.1210/JC.2008-1345